Cytobiologics

Research & Development

Plasma research and development is a critical process that involves the identification, testing, and commercialization of plasma-derived therapies to treat a variety of diseases.

1. Discovery

The discovery phase involves identifying new molecules and therapeutic targets that have the potential to treat a variety of diseases.

2. Preclinical testing

Preclinical testing is carried out to assess candidate compounds for safety and efficacy when they have been identified.

3. Clinical trials

If a molecule or therapy shows promise in preclinical testing, it may proceed to clinical trials.

4. Regulatory approval

After successful completion of clinical trials, regulatory approval must be obtained.

5. Commercialization

Once regulatory approval has been obtained, the therapy can be commercialized and made available to patients. This may involve manufacturing the therapy at large scale, establishing distribution networks, and developing marketing strategies to raise awareness and increase uptake.